HighPoint Blog

Ruven Eul, Associate Director

Ruven is an Associate Director of the European Life Sciences team based out of Zug, Switzerland. Ruven has worked for around 8 years in Germany for much of his career at companies such as Pfizer and BMS in local, regional and global roles. Ruven comes from a deep background in the areas of Commercial Excellence with strong domain experience in CRM, Commercial Analytics, and Tendering working with industry leading products such as Model N, Revitas and Veeva. Ruven has been involved in rollouts of Veeva as a Deployment Lead for multiple countries and as a Subject Matter Expert in Tender Management projects, as well as interim management for Global Tender Management. In addition Ruven has provided strong delivery and advisory on Global Revenue Management Assessments.
Find me on:

Recent Posts

Nowadays, it’s a well-known fact that tender management is essential across most markets. Thus, as part of your tender management strategy, you must setup a network of tender champions or a global tender network. However to address the specifics of tendering across various markets and diverse portfolios, a tender management organization needs to be built.

Within any life science organization,...

Read More

Tenders set the stage in the new procurement landscape

The importance of tenders is rising. Tendering has become a new, standard method of entry into the procurement game in most European countries, and even across Asia, Middle East and Latin America. This competitive form of procurement procedure by national, regional or local tender authority is often heavily regulated by law.

The most...

Read More

As part of the actions linked to a single market strategy, eForm aims at facilitating the management of data in the European procurement process. This new European legislation would apply to Life Science tenders as well. The increased importance of tendering  . The updates will potentially impact all the different types of tender existing within the European Framework. To fill some of the gaps...

Read More
Read More

With more than 30% of the pharmaceutical market now utilizing, a significant portion of the Life Sciences industry’s revenue is being subjected to tendering. It’s hard to think of a more imperative way to see, the time is now to adapt and master tendering. The tendering process can be divided into 5 essential phases: Awareness, Evaluation, Response, Fulfillment, and Tracking. All phases are...

Read More

To successfully compete in the tender and contracting (T&C) market, Life Sciences companies require a strong and robust tender organization with a global-to-local tender strategy. This “Think Global, Act Local” strategy can be achieved by implementing a Global Tender Network with country Tender Champions where the whole organization partners with multiple, cross functional, corporate groups to...

Read More

Tender management is becoming increasingly important these days. Twenty five percent (25%) of the pharmaceutical market is now considered to be traded through some form of tender, and this percentage is expected to grow even further. The prevalence of tendering is nowadays expanding from generic to specialized drugs, forcing even specialized manufacturers to become participants in tender.

Read More

Tag